Leaflet AXABAL 150mg modified release tablets

Product code:
W70875001
Quantity:
30
Indicated for:
depression; smoking cessation
Route of administration:
oral
Substance:
bupropion (antidepressant)
ATC
N06AX12 — Nervous system | Antidepressants | Other antidepressants

Precautions:

Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Seizure risk

This medicine may increase the risk of seizures.

Suicidal ideation / mental changes

Seek medical help if suicidal thoughts or major behavior changes occur.

Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Bupropion is a medication used for the treatment of major depression and as an aid in smoking cessation. It is a dopamine and norepinephrine reuptake inhibitor that helps improve mood and reduce nicotine withdrawal symptoms.

The medication is taken orally, usually once or twice daily, as directed by a doctor. The dosage is adjusted based on the patient's response and the purpose of treatment.

Common side effects include insomnia, dry mouth, nausea, dizziness, and anxiety. In rare cases, more severe adverse effects such as seizures or severe allergic reactions may occur.

Bupropion is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, it is important for patients to strictly adhere to the prescribed dosage to minimize the risk of serious adverse effects.

General data about AXABAL 150mg

Substance:
bupropion
Date of latest medicines list:
01-06-2026
Product code:
W70875001
Concentration:
150mg
Pharmaceutical form:
modified release tablets
Quantity:
30
Product type:
Generic medicine
Price:
37.16 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
TERAPIA S.A. - ROMANIA
Holder:
TERAPIA SA - ROMANIA
Number:
15784/2025/01
Shelf life:
2 years

Concentrations available for bupropion

  • 150mg
  • 300mg

Combinations with other substances

Compensation lists for AXABAL 150mg Terapia

B - Sublist B with 50% discount from the reference price

Price
37.16 RON
Copayment
18.58 RON
Patient
18.58 RON